iNova Pharmaceutical's acquisition of Juno PC set to receive Australian regulatory scrutiny
MLex Summary: The proposed acquisition of Australian pharmaceutical joint venture Juno PC by iNova Pharmaceuticals (Australia) will be reviewed by the country’s competition regulator. In a market inquiries letter released today,...To view the full article, register now.
Already a subscriber? Click here to view full article